Skip to main content
SpringerLink
Log in

Pathophysiologie und Ätiopathogenese/Differenzialdiagnostik der Diabetesformen

  • Chapter
Pädiatrische Endokrinologie und Diabetologie

  • 2697 Accesses

Zusammenfassung

Diabetes mellitus ist eine Stoffwechselerkrankung charakterisiert durch eine chronische Hyperglykämie als Resultat einer fehlenden Insulinsekretion, einer gestörten Insulinwirkung oder beider (WHO u. IDF 2006).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  • Achenbach P, Warncke K, Reiter J et al. (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53: 384–389

    Article  CAS  PubMed  Google Scholar 

  • Aguilar-Bryan L, Bryan J (2008) Neonatal diabetes mellitus. Endocr Rev 29: 265–291

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Diabetes Care 23: 381–389

    Article  Google Scholar 

  • American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32 (Suppl 1): S62–S67

    Article  PubMed Central  Google Scholar 

  • Bastra MR, Aanstoot HJ, Herbrink P (2001) Prediction and diagnosis of type 1 diabetes using b-cell autoantibodies. Clin Lab 47: 497–507

    Google Scholar 

  • Charpentier N, Hartmann R, Deiss D, Danne T, Kordonouri O (2008) Prävalenz und Bedeutung der diabetes-spezifischen Autoantikörper GADA, IA-2A und IAA zum Zeitpunkt der Manifestation eines Typ-1 Diabetes bei 341 Kindern und Jugendlichen. Diabetol Stoffw 3: 159–165

    Article  Google Scholar 

  • Craig ME, Hattersley A, Donaghue K, International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006–2007 (2006) Definition, epidemiology and classification. Pediatr Diabetes 7: 343–351

    Google Scholar 

  • Drachenberg CB, Klassen DK, Weir MR et al. (1999) Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68: 396–402

    Article  CAS  PubMed  Google Scholar 

  • Edghill EL, Flanagan SE, Patch AM et al. (2008) Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57: 1034–1042

    Article  CAS  PubMed  Google Scholar 

  • Ellard S, Bellanné-Chantelot C, Hattersley AT, European Molecular Genetics Quality Network (EMQN) MODY Group (2008) Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51: 546–553

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345: 971–980

    Article  CAS  PubMed  Google Scholar 

  • Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT (2006) Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 49: 1190–1197

    Article  CAS  PubMed  Google Scholar 

  • Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. CMAJ 175: 165–170

    Article  PubMed Central  PubMed  Google Scholar 

  • Gloyn AL, Diatloff-Zito C, Edghill EL et al. (2006) KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 14: 824–830

    Article  CAS  PubMed  Google Scholar 

  • Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K, International Society for Pediatric and Adolescent Diabetes ISPAD Clinical Practice Consensus Guidelines 2006–2007 (2006) The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 7: 352–360

    Google Scholar 

  • Herskowitz-Dumont R, Wolfsdorf JI, Jackson RA, Eisenbarth GS (1993) Distinction between transient hyperglycemia and early insulindependent diabetes mellitus in childhood: a prospective study of incidence and prognostic factors. J Pediatr 123: 347–354

    Article  CAS  PubMed  Google Scholar 

  • Koch C, Rainisio M, Madessani U et al. (2001) Presence of cystic fibrosisrelated diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32: 343–350

    Article  CAS  PubMed  Google Scholar 

  • Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C (1994) Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 83: 72–77

    Article  CAS  PubMed  Google Scholar 

  • Maes BD, Kuypers D, Messiaen T et al. (2001) Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 72: 1655–1661

    Article  CAS  PubMed  Google Scholar 

  • O’Riordan SM, Robinson PD, Donaghue KC, Moran A (2008) Management of cystic fibrosis-related diabetes. Pediatr Diabetes 9: 338–344

    Article  PubMed  Google Scholar 

  • Owen K, Hattersley AT (2001) Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 15: 309–323

    Article  CAS  PubMed  Google Scholar 

  • Pearson ER, Flechtner I, Njolstad PR et al. (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355: 467–477

    Article  CAS  PubMed  Google Scholar 

  • Pui CH, Burghen GA, Bowman WP, Aur RJ (1981) Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr 99: 46–50

    Article  CAS  PubMed  Google Scholar 

  • Raeder H, Johansson S, Holm PI et al. (2006) Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 38: 54–62

    Article  CAS  PubMed  Google Scholar 

  • Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376–1379

    Article  CAS  PubMed  Google Scholar 

  • Rich SS, Onengut-Gumuscu S, Concannon P (2009) Recent progress in the genetics of diabetes. Horm Res 71 (Suppl 1): 17–23

    Article  CAS  PubMed  Google Scholar 

  • Schatz DA, Bingley PJ (2001) Update on major trials for the prevention of type 1 diabetes mellitus: the American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT). J Pediatr Endocrinol Metab 14 (Suppl 1): 619–622

    PubMed  Google Scholar 

  • Shehadeh N, On A, Kessel I et al. (1997) Stress hyperglycemia and the risk for the development of type 1 diabetes. J Pediatr Endocrinol Metab 10: 283–286

    Article  CAS  PubMed  Google Scholar 

  • The Expert Committee on the Diagnosis and Classification of Diabetes mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160–3167

    Article  Google Scholar 

  • Valerio G, Franzese A, Carlin E, Pecile P, Perini R, Tenore A (2001) High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr 90: 618–622

    Article  CAS  PubMed  Google Scholar 

  • WHO (World Health Organization), IDF (International Diabetes Federation) (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation 2006 Geneva, Switzerland

    Google Scholar 

  • Wildin RS, Smyk-Pearson S, Filipovich AH (2002) Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39: 537–545

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Allgemeine Kinderheilkunde III Abteilung Diabetologie/Endokrinologie, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee 12, D-30173, Hannover

    Prof. Dr. med. Olga Kordonouri

Authors
  1. Prof. Dr. med. Olga Kordonouri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kordonouri, O. (2010). Pathophysiologie und Ätiopathogenese/Differenzialdiagnostik der Diabetesformen. In: Pädiatrische Endokrinologie und Diabetologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01912-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-01912-8_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-01911-1

  • Online ISBN: 978-3-642-01912-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation